The Development Course of General Technology Group Pharmaceutical Holding Co., Ltd.

In 2000, the group invested in Shanghai Fudan Zhangjiang Biomedical Co., Ltd. (HK823 1) and entrusted it to General Medical Control Company for management. Fudan Zhangjiang Company is mainly engaged in the research and development of high-tech pharmaceutical products with independent intellectual property rights. In 2002, it was listed on Hong Kong Growth Enterprise Market.

In 200 1 year, the group invested in Hainan Alliance Pharmaceutical Co., Ltd. and established Hainan General Alliance Pharmaceutical Co., Ltd., which was entrusted to the general medical control company for management. Hainan Alliance Company is mainly engaged in the research, development, production and sales of new drugs such as genetic engineering drugs and biochemical drugs. It has modern production lines and genetic engineering workshops for tablets, soft capsules, hard capsules, small-volume injections and freeze-dried injections that have passed the national GMP certification, as well as a nationwide marketing network system.

200 1, the group acquired Hainan Sanyo Linde Pharmaceutical Co., Ltd. and established Hainan General Sanyo Pharmaceutical Co., Ltd. Sanyo's main products, such as enzyme-resistant and highly effective antibiotics, have strong competitiveness and high market share in the domestic market; The company has modern production lines such as penicillin, cephalosporin, powder injection, freeze-dried powder injection, water injection, capsules and granules, and has passed the national GMP certification as a whole. After the asset replacement, it was allocated to China Pharmaceutical and Health Products Co., Ltd. (SH600056) and became its main production enterprise.

In 2004, the Group completed the acquisition of part of the equity of Xi Anlijun Pharmaceutical Co., Ltd..

In 2006, General Medical Control Company indirectly controlled Hubei Yike Pharmaceutical Co., Ltd. by holding Hubei Xinyi Company. The company has inherited the research and development resources of Hubei Medical Engineering College, and its production technology and quality control are at the leading level among similar enterprises in China, especially the antiviral varieties represented by ganciclovir, which have high brand awareness and market dominance.